))
Envoy Medical – Developing a Disruptive Fully Implanted Cochlear Implant for Patients with Severe Hearing Loss
Manage episode 426792722 series 3486351
内容由Water Tower Research提供。所有播客内容（包括剧集、图形和播客描述）均由 Water Tower Research 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Envoy’s CEO Brent Lucas and Envoy’s CFO David Wells join WTR’s Thierry Wuilloud and Tim Regan to discuss the company’s Acclaim cochlear implant. The Acclaim has two key differentiating characteristics compared to the current market leading cochlear implants: First, it uses the ear to capture sound, unlike the current standard devices which capture sound externally behind the ear. Second, the device is completely implanted, unlike the other devices which are partially implanted, with elements resting on the skull, typically above the ear, and posing associated challenges (think Lasik vs contact lenses or glasses). Brent and David discuss the Acclaim, its modus operandi, patient profiles, reimbursement issues, approval process, and the company’s financial position and needs to shepherd the product through approval and commercialization.
96集单集
分享
